Module IX - A Review of Serotonin Syndrome and Neuroleptic Malignant Syndrome

Thursday December 3, 1998 - Question 13

Which of the following statements regarding treatment of NMS is correct?

A. Specific pharmacologic therapies should be tailored to correct the predominant symptoms.
B. Sodium bicarbonate should be avoided in persons with rhabdomyolysis.
C. Vasodilators have no role in the treatment of persons with NMS.
D. Bromocriptine (Parlodel), a dopamine antagonist, may be useful to reduce body core temperature in persons not responding to external cooling or benzodiazepines.
E. Dantrolene (Dantrium), a dopamine agonist, may be useful in cases of severe muscle rigidity and contraction not responsive to benzodiazepines.
 
 

Discussion